Gene · 7178
Papers1,918
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,918
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential of histamine release factor for the utilization as a universal vaccine antigen against poultry red mites, tropical fowl mites, and northern fowl mites. | J Vet Med Sci | 2025 | 39567007 | PubTator, text mining | PubMed |
| Cell Fate Dynamics Reconstruction Identifies TPT1 and PTPRZ1 Feedback Loops as Master Regulators of Differentiation in Pediatric Glioblastoma-Immune Cell Networks. | Interdiscip Sci | 2025 | 39420135 | PubTator, text mining | PubMed |
| High plasma levels of fortilin are associated with cardiovascular events in patients undergoing coronary angiography. | Heart Vessels | 2025 | 39342070 | PubTator, text mining | PubMed |
| Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39287672 | PubTator, text mining | PubMed |
| AI-based Virtual Screening of Traditional Chinese Medicine and the Discovery of Novel Inhibitors of TCTP. | Curr Comput Aided Drug Des | 2025 | 38310576 | PubTator, text mining | PubMed |
| Evaluation of lncRNAs as Potential Biomarkers for Diagnosis of Metastatic Triple-Negative Breast Cancer through Bioinformatics and Machine Learning. | Iran J Biotechnol | 2024 | 39737204 | PubTator, text mining | PubMed |
| Survival analysis based on an enhanced Rayleigh-inverted Weibull model. | Heliyon | 2024 | 39687856 | PubTator, text mining | PubMed |
| A new two-parameter Rayleigh distribution: Statistical properties, actuarial measures, regression analysis, and applications. | Heliyon | 2024 | 39676833 | PubTator, text mining | PubMed |
| An extended Rayleigh Weibull model with actuarial measures and applications. | Heliyon | 2024 | 39668969 | PubTator, text mining | PubMed |
| Inferring single-cell resolution spatial gene expression via fusing spot-based spatial transcriptomics, location, and histology using GCN. | Brief Bioinform | 2024 | 39656774 | PubTator, text mining | PubMed |
| A fully automated morphological analysis of yeast mitochondria from wide-field fluorescence images. | Sci Rep | 2024 | 39627480 | PubTator, text mining | PubMed |
| Exploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome based on high-throughput sequencing technology. | J Ovarian Res | 2024 | 39529075 | PubTator, text mining | PubMed |
| Expression of the lncRNA TPT1-AS1 in lung squamous cell carcinoma and its prognostic value. | Discov Oncol | 2024 | 39527376 | PubTator, text mining | PubMed |
| Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays. | Elife | 2024 | 39526730 | PubTator, text mining | PubMed |
| Plasma Proteomics of Type 2 Diabetes, Hypertension, and Co-Existing Diabetes/Hypertension in Thai Adults. | Life (Basel) | 2024 | 39459569 | PubTator, text mining | PubMed |
| The multifaceted potential of TPT1 as biomarker and therapeutic target. | Heliyon | 2024 | 39397949 | PubTator, text mining | PubMed |
| Long non-coding RNA TPT1-AS1 inhibits ferroptosis in ovarian cancer by regulating GPX4 via CREB1 regulation. | Am J Reprod Immunol | 2024 | 39141012 | PubTator, text mining | PubMed |
| The lncRNA TPT1-AS1 promotes the survival of neuroendocrine prostate cancer cells by facilitating autophagy. | Am J Cancer Res | 2024 | 38859837 | PubTator, text mining | PubMed |
| Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy. | Cancer Cell Int | 2024 | 38835077 | PubTator, text mining | PubMed |
| The TCTP is essential for ovarian development and oviposition of Rhipicephalus haemaphysaloides. | Vet Parasitol | 2024 | 38781831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7178/papers?page=4